Charles E. DiLiberti

Statistics

Publications

Citations

248

H-Index

Active since

2007

Affiliations

Center for Drug Evaluation and Research(Current)

United States Food and Drug Administration

Research Triangle Park Foundation

GlaxoSmithKline (United States)

Montclair State University

Charles E. DiLiberti is an author at Center for Drug Evaluation and Research specializing in public health, bioequivalence study design, and crossover designs.

Publications per year

2007–2018

Publications

Sequential design approaches for bioequivalence studies with crossover designs

Diane Potvin, Charles E. DiLiberti, Walter W. Hauck et al. · Pharmaceutical Statistics · 2007 · 95 citations

Public Health, Biostatistics, Bioequivalence +16

Additional results for ‘Sequential design approaches for bioequivalence studies with crossover designs’

Timothy H. Montague, Diane Potvin, Charles E. DiLiberti et al. · Pharmaceutical Statistics · 2011 · 46 citations · Full text

Public Health, Biostatistics, Pharmacokinetics +17

Effects on serum hormone levels of low-dose estrogen in place of placebo during the hormone-free interval of an oral contraceptive

Kathleen Z. Reape, Charles E. DiLiberti, Christopher H. Hendy et al. · Contraception · 2007 · 32 citations

Medicine, Endocrinology, Gynecology +17

Steady-state pharmacokinetics of an extended-regimen oral contraceptive with continuous estrogen

Charles E. DiLiberti, Christine M. O'Leary, Christopher H. Hendy et al. · Contraception · 2010 · 26 citations

Medicine, Pharmacokinetics, Pharmacology +16

Optimal adaptive sequential designs for crossover bioequivalence studies

Jialin Xu, Charles Audet, Charles E. DiLiberti et al. · Pharmaceutical Statistics · 2015 · 25 citations

Public Health, Biostatistics, Bioequivalence +15

1–5 of 6